Parx Materials

Parx Materials is a Netherlands-based biotech startup founded in 2012 with a focus on developing innovative antibacterial plastics. The company's slogan, "Harnessing biomimetic innovation to create 100% safe, biocompatible antibacterial plastics, ensuring protection for humans, animals, and the environment," reflects its core mission. Parx Materials aims to address the challenges posed by bacteria and viruses by leveraging bio-inspired technology that creates hygienic surfaces, reducing the presence of microorganisms by 99.9% and higher, while ensuring ecological and biodiversity safety. Notably, the company's approach differs from traditional methods reliant on biocides and antibiotics, as Parx Materials uses a body's own trace element incorporated into materials without inducing antimicrobial resistance. Their technology effectively controls colonization by bacteria and viruses by preventing adhesion and biofilm formation, without the use of biocides. Parx Materials' commitment to sustainability and innovation has garnered attention, with MassChallenge providing Non-Equity Assistance investment in October 21, 2020. This unique positioning has positioned Parx Materials as a groundbreaking player in the biotechnology, healthcare, and manufacturing industries, setting the stage for the company's continued growth and influence. Moreover, by being stock listed on Euronext Access in Paris under the ticker symbol MLPRX, Parx Materials has underscored its commitment to transparency and accessibility, further bolstering its appeal to potential investors and partners.